761

Risk factors for diagnosed opioid abuse and dependence among individuals using opioids for chronic non-cancer pain

Mark Edlund, MD, PhD1, Diane E. Steffick, PhD1, Teresa Hudson, PharmD1, Katherine M. Harris, PhD2, and Mark D. Sullivan, MD, PhD3. (1) Psychiatry, University of Arkansas for Medical Sciences, 2200 Fort Roots Drive, North Little Rock, AR 72114, (2) Health Program, RAND Corp., 1200 South Hayes Street, Arlington, VA 22202, (3) Psychiatry Department, University of Washington, 1959 Northeast Pacific Street, Seattle, WA 98195

A central question in prescribing opioids for chronic non-cancer pain (CNCP) is how to best balance the risk of opioid abuse and dependence with the benefits of pain relief. To achieve this balance, clinicians need an understanding of the risk factors for opioid abuse, an issue that is only partially understood. We conducted a secondary data analysis of regional VA longitudinal administrative data (years 2002-2005) for chronic users of opioids for CNCP (n=15,390) to investigate risk factors for the development of diagnosed opioid abuse or dependence among these individuals. We analyzed four broad groups of possible risk factors: (i) non-opioid substance abuse disorders, (ii) physical health disorders, including painful physical health disorders, (iii) mental health disorders, and (iv) socio-demographic factors. In adjusted models a diagnosis of non-opioid substance abuse was the strongest predictor of opioid abuse/dependence (OR=2.42, p<0.001). Mental health disorders were moderately strong predictors (OR=1.47, p=0.002) of opioid abuse/dependence. However, the prevalence of mental health disorders prevalence was much higher than the prevalence of non-opioid substance abuse disorders (45.6% vs. 7.9%), suggesting that mental health disorders may account for more of the population attributable risk for opioid abuse than does non-opioid substance abuse. Males, younger adults, and patients with back pain were more likely to have opioid abuse/dependence. Clinicians need to carefully screen for substance abuse and mental health disorders in candidates for opioid therapy and facilitate appropriate treatment of these disorders.